EligibleTrials

Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma

Recruiting · NCT07220876 · Interventional (participants receive a specific treatment) · Lead sponsor: Avisi Technologies Inc.

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

VisiPlate Glaucoma Implant

What this trial is about

A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial

Who can take part

Age range
45 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

12 locations listed across 7 US states.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.